Globally Leading Solution for Hepatitis E Prevention and Control
Hepatitis E is an acute infectious disease caused by the Hepatitis E virus (HEV), representing a significant global public health challenge, particularly in developing countries. Drawing on years of dedicated research in the field, Wantai Biopharm has developed a globally advanced, integrated solution for the screening and prevention of Hepatitis E.
We offer the world’s only urine-based Hepatitis E antigen detection product, the first preventive Hepatitis E vaccine globally, and HEV IgG and IgM antibody assays recognized as the “gold standard” in diagnostics. Together, these innovations form a comprehensive screening and prevention system, delivering an all-in-one solution for effective hepatitis E control and prevention.
Globally Innovative Product Series
Three core Hepatitis E products to build a complete Hepatitis E prevention and control system
Hepatitis E Antibody Detection Test
The HEV IgM and HEV IgG detection tests are known as the new-generation serological marker "gold standard" for acute Hepatitis E infection and have been widely recognized internationally.
Hepatitis E Urine Antigen Detection
The world's only product capable of detecting Hepatitis E antigen through urine samples. It is non-invasive, convenient, and accurate, greatly improving the accessibility of Hepatitis E screening and patient compliance.
Hepatitis E Preventive Vaccine
The world's first Hepatitis E preventive vaccine approved for marketing. Clinical trials have confirmed that its protective efficacy is as high as 100%, providing a fundamental solution for Hepatitis E prevention and control.
Hepatitis E Screening and Prevention Solution
Wantai Biopharm’s integrated solution for hepatitis E screening and prevention has been successfully implemented across numerous provinces and cities in China. By establishing a closed-loop prevention and control system encompassing screening, monitoring, prevention, and management, the incidence of Hepatitis E has been significantly reduced—earning strong recognition from public health authorities. We provide a comprehensive package of products, technologies, training, and ongoing support to help regions build robust prevention and control systems, achieving the goals of early screening, early detection, and early intervention.
- Screening of High-risk GroupsRegular screening for high-risk groups such as pregnant women, patients with liver diseases, and immunocompromised people
- Hepatitis E Epidemic MonitoringEstablish Hepatitis E monitoring sentinel sites to timely monitor the prevalence of Hepatitis E in the region
- Hepatitis E VaccinationVaccinate high-risk groups with the Hepatitis E vaccine to establish an immune barrier
- Health Education and PromotionRaise public awareness of Hepatitis E and prevention awareness
Integrated Screening and Prevention Solution
From early screening to preventive immunization, build a comprehensive Hepatitis E prevention and control system
Whole-process Hepatitis E Prevention and Control Strategy
Screening of High-risk Groups
Conduct Hepatitis E antibody/antigen tests on high-risk populations to detect the changes of infected individuals at an early stage.
Epidemic Monitoring
Conduct epidemiological monitoring of Hepatitis E in specific regions to provide support for prevention and control decisions
Vaccination
Vaccinate susceptible groups with the Hepatitis E vaccine to effectively prevent Hepatitis E infection
Continuous Tracking
Establish health records for long-term health monitoring and management
For more information : wtexport@ystwt.com
Filing Number:(京)网药械信息备字（2025）第 00190 号
|
Copyright©Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
|
京公网安备11011402010353号 
Alibaba Cloud provides cloud computing and security services.|
It supports
|
Powered by CloudDream
|
Terms Of Use|
Privacy Statement